- ‘Welcome to the edge of freedom’: Biden’s boots touch down in DMZ
- Obama: Hole U.S. ‘digging out of’ requires billions more in unemployment benefits
- Obama’s regulatory agenda will cost U.S. economy $143B next year: report
- Patriot Act author on James Clapper: Fire, prosecute him
- Russia P.M. Medvedev: No amnesty for political prisoners
- Michigan GOP Senate hopeful reminds government is the ‘servant’
- Christmas, by Congress: Members mull a 15-cent tax on trees
- U.S. unemployment falls to five-year low of 7 percent; 203K jobs added
- World mourns Nelson Mandela and celebrates his life; burial set for Dec. 15
- Bill O’Reilly reminds: Nelson Mandela ‘was a communist’
NIH plans center to spur creation of new drugs
WASHINGTON (AP) - The nation’s premier research agency plans to open a new center this fall to spur creation of medications because of concern that exciting discoveries aren’t being turned into treatments fast enough.
The plan is on track despite the increasingly likely prospect of budget cuts for the venerable National Institutes of Health, agency chief Dr. Francis Collins said Wednesday.
The idea: Do more of the risky early-stage research into promising compounds that drug companies are increasingly reluctant to invest in. It’s a period called “the valley of death” because so many of those early experiments fail.
“The valley of death needs to become a valley that leads to life,” Collins told reporters. “The time is right even in a difficult budget environment, maybe especially in a difficult budget environment.”
That kind of drug-related research isn’t new for the NIH. The cancer drug taxol and AIDS drug AZT, for example, originated from NIH work, Collins noted, and agency researchers have 550 projects under way devoted to various medications, vaccines or medical devices. He cited recent research that found 20 percent of innovative new medications that hit the market in recent years originated from NIH-funded research _ as the drug industry’s own research productivity has declined.
The National Center for Advancing Translational Sciences would bring much of NIH’s current drug development research _ about $700 million worth, from a $30 billion budget _ under one roof so scientists could better collaborate, Collins said. It also will explore new techniques to predict, for instance, which experimental medications will be safe enough to test in people faster than is done today.
The plan has drawn some objections by researchers and others concerned about the dismantling of another NIH center at the same time, projects that Collins said will be taken over by other parts of the agency.
But some high-profile patient advocacy groups are praising the change. Fewer than 200 of 7,000 rare diseases have an available therapy, said James O’Leary of the Genetic Alliance.
“That’s just too slow,” he said. “This translational medicine focus is critical to the mission of NIH.”
The Bethesda, Md.-based NIH plans to open the center Oct. 1.
- Bill OReilly reminds: Nelson Mandela was a communist
- Obama administration issues permits for wind farms to kill more eagles
- Spike in battlefield deaths linked to restrictive rules of engagement
- PRUDEN: British press horrified as London's new mayor dares to proclaim the truth
- Obama: Hole U.S. 'digging out of' requires billions more in unemployment benefits
- Rush Limbaugh: Obama trying to make Mandela death about himself
- Kill team: Obama war chiefs widen drone death zones
- NAPOLITANO: Pope Francis should be saving souls, not pocketbooks
- 'Dude, I'm dreading that I will have to go': Czech prime minister on Mandela funeral
- John Boehner says GOP should support gay candidates: I do
Independent voices from the The Washington Times Communities
Find the latest news and happening that effect those in the Washington D.C., Northern Virginia and Maryland Metro region.
A stat-head’s outlook, direct from his worn in couch cushion.
Classical music and the performing arts: news and reviews you can use.
Covering the world of soccer, including the World Cup, Major League Soccer, D.C. United and the English Premier League and other interesting sporting events.
White House pets gone wild!